🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/06/2022 | 55,76 | 55,76 | 52,72 | 53,63 | -3,31% | 5,46% | 183.223 |
| 31/05/2022 | 56,03 | 56,49 | 54,59 | 55,46 | -1,81% | 3,40% | 286.456 |
| 27/05/2022 | 54,53 | 56,83 | 54,09 | 56,49 | +4,60% | 5,02% | 182.261 |
| 26/05/2022 | 52,33 | 54,44 | 52,33 | 54,01 | +4,06% | 4,03% | 180.017 |
| 25/05/2022 | 50,54 | 52,40 | 50,54 | 51,90 | +2,00% | 3,69% | 165.590 |
| 24/05/2022 | 51,25 | 51,57 | 49,47 | 50,88 | -2,34% | 4,10% | 212.878 |
| 23/05/2022 | 52,36 | 52,67 | 50,81 | 52,10 | +0,76% | 3,55% | 238.526 |
| 20/05/2022 | 52,51 | 52,83 | 49,65 | 51,70 | +0,17% | 6,05% | 190.116 |
| 19/05/2022 | 51,67 | 52,06 | 50,35 | 51,62 | -0,28% | 3,31% | 239.649 |
| 18/05/2022 | 54,91 | 56,04 | 51,07 | 51,76 | -8,81% | 9,07% | 309.700 |
| 17/05/2022 | 55,60 | 57,23 | 55,04 | 56,76 | +4,91% | 3,94% | 175.849 |
| 16/05/2022 | 53,69 | 54,67 | 52,42 | 54,10 | +0,90% | 4,18% | 216.245 |
| 13/05/2022 | 51,38 | 53,66 | 50,29 | 53,62 | +6,89% | 6,57% | 270.426 |
| 12/05/2022 | 48,53 | 51,27 | 48,53 | 50,17 | +2,21% | 5,63% | 229.069 |
| 11/05/2022 | 51,74 | 53,47 | 48,69 | 49,08 | -6,14% | 9,24% | 248.465 |
| 10/05/2022 | 52,69 | 54,07 | 50,41 | 52,30 | +3,19% | 6,96% | 247.984 |
| 09/05/2022 | 54,60 | 55,76 | 50,30 | 50,68 | -8,18% | 10,00% | 377.026 |
| 06/05/2022 | 55,68 | 57,43 | 54,13 | 55,20 | -2,43% | 5,93% | 278.441 |
| 05/05/2022 | 59,73 | 60,50 | 54,97 | 56,57 | -5,54% | 9,26% | 546.142 |
| 04/05/2022 | 58,08 | 60,21 | 56,01 | 59,89 | +2,77% | 7,23% | 325.249 |
| 03/05/2022 | 59,94 | 60,51 | 58,13 | 58,27 | -2,77% | 3,98% | 188.994 |
| 02/05/2022 | 58,11 | 59,93 | 57,66 | 59,93 | +3,46% | 3,91% | 328.294 |
| 29/04/2022 | 58,02 | 59,77 | 57,09 | 57,93 | -0,58% | 4,61% | 240.129 |
| 28/04/2022 | 59,03 | 59,18 | 56,66 | 58,27 | +0,73% | 4,27% | 149.560 |
| 27/04/2022 | 58,67 | 59,74 | 57,65 | 57,84 | -1,50% | 3,57% | 230.672 |
| 26/04/2022 | 60,98 | 60,98 | 58,55 | 58,72 | -5,18% | 3,99% | 345.927 |
| 25/04/2022 | 59,93 | 62,33 | 59,93 | 61,93 | +2,06% | 4,01% | 210.314 |
| 22/04/2022 | 60,85 | 61,99 | 59,84 | 60,68 | -0,39% | 3,53% | 213.840 |
| 21/04/2022 | 64,91 | 64,91 | 60,51 | 60,92 | -4,98% | 6,78% | 271.869 |
| 20/04/2022 | 64,97 | 65,70 | 64,07 | 64,11 | -0,40% | 2,51% | 137.858 |